What medications are used to improve cognitive awareness or insight?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications for Improving Cognitive Awareness and Insight

Cholinesterase inhibitors (donepezil, galantamine, rivastigmine) and memantine may be considered for improving cognitive awareness in patients with vascular cognitive impairment, though their effectiveness is not well established. 1

Pharmacological Options by Condition

For Vascular Cognitive Impairment

  • Cholinesterase inhibitors (donepezil, galantamine, rivastigmine)

    • Recommended for selected patients with vascular cognitive impairment 1
    • May improve cognitive function, including awareness
    • Consider when cognitive impairment affects insight and daily functioning
  • Memantine (NMDA receptor antagonist)

    • May be considered for vascular cognitive impairment 1
    • Works through different mechanism than cholinesterase inhibitors
    • Can be used alone or in combination with cholinesterase inhibitors

For Post-Stroke Cognitive Impairment

  • SSRIs/SNRIs
    • Evidence is equivocal for improving cognitive outcomes post-stroke 1
    • May indirectly improve insight by treating depression which often co-occurs
    • Consider when cognitive impairment is accompanied by depressive symptoms

For Psychotic Disorders with Impaired Insight

  • Antipsychotic medications combined with psychosocial interventions
    • Medium effect size (0.683) for improving insight in psychotic disorders 2
    • More effective than either intervention alone
    • Target both psychotic symptoms and cognitive processing

Cautions and Considerations

Medication Selection

  1. Avoid medications with anticholinergic properties in elderly patients

    • Medications like oxybutynin can worsen cognitive function and decrease awareness 3
    • The American Geriatrics Society recommends avoiding these medications due to high risk of cognitive impairment 3
  2. Consider cardiovascular risk factors

    • Treating hypertension may reduce risk of dementia 1
    • For patients with cognitive disorders with suspected vascular contribution, antihypertensive therapy should be strongly considered for diastolic BP ≥90 mmHg or systolic BP ≥140 mmHg 1
  3. Medication risks vs. benefits

    • Statin therapy has not been shown to negatively impact cognitive function 1
    • Monitor for side effects that could worsen cognitive function

Non-Pharmacological Approaches

  1. Cognitive Behavioral Therapy (CBT)

    • Small but significant effect (0.235) for improving insight 2
    • Particularly useful in psychotic disorders
  2. Psychoeducation

    • Medium effect size (0.613) for improving insight 2
    • Patients receiving psycho-education showed greater symptom awareness compared to patients treated with drugs alone 4
  3. Transcranial Direct Current Stimulation (tDCS)

    • Very large and significant improvement of insight (1.153) when applied over left fronto-temporal cortex 2
    • Effects may last at least a month after intervention
    • Still considered experimental
  4. Cognitive Rehabilitation

    • Reasonable approach to improve attention, memory, and executive functioning 1
    • Use strategies that consider practice, compensation, and adaptive techniques

Monitoring and Follow-up

  • Regularly assess cognitive insight using validated tools like the Beck Cognitive Insight Scale (BCIS) 5, 6
  • Monitor for differences in awareness of clinical symptoms versus neurocognitive symptoms, as patients often have less insight into cognitive deficits than clinical symptoms 7
  • Consider more frequent follow-up for patients showing rapid cognitive decline 1

Common Pitfalls to Avoid

  • Assuming uniform insight across symptom domains: Patients often have different levels of insight into clinical versus cognitive symptoms 7
  • Overlooking vascular risk factors: Controlling vascular risk factors is crucial, especially in patients with rapid cognitive decline 1
  • Focusing solely on pharmacological approaches: Combined approaches (medication plus psychosocial interventions) show better outcomes for improving insight 2
  • Neglecting to differentiate types of cognitive impairment: Different cognitive disorders may respond differently to various interventions

When selecting medications to improve cognitive awareness and insight, prioritize treating the underlying condition while avoiding medications with known negative cognitive effects, and consider combining pharmacological with non-pharmacological approaches for optimal outcomes.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.